Australia's Codeine Reverse-Switch “Vindicated” By 50% Drop In Supply

A 50% drop in the supply of codeine-containing medicines in Australia last year shows that the decision to reverse-switch the drug was correct, according to the Australian Medical Association.   

Opium_Poppy
Codeine Is An Analgesic Extracted From Opium Poppies • Source: Shutterstock

Australia’s decision last year to reverse-switch codeine from a non-prescription to a prescription-only medicine has been “vindicated” by data showing a 50% drop in the drug’s supply, according to the Australian Medical Association.

“The Therapeutic Goods Administration and the Federal Government held firm in the face of great pressure from pharmacy lobby groups,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

PAGB: UK Gov Must Invest In Self-Care To Realize ‘Untapped Potential’

 
• By 

Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.

FDA Takes World Tour In Recent OTC Warnings

 

FDA Center for Drug Evaluation and Research Office of Manufacturing Quality, Office of Compliance and Office of Unapproved Drugs & Labeling Compliance recently advise Indian, Canadian and US firms about GMP problems.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By 

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.